Factor | Comparison | Hazard Ratio | Lower 95%CL | Upper 95%CL | P-value |
---|---|---|---|---|---|
Pathologic Stage | IIA vs. I | 0.52 | 0.19 | 1.40 | 0.1953 |
IIB vs. I | 1.70 | 0.75 | 3.87 | 0.2067 | |
III vs. I | 1.19 | 0.23 | 6.15 | 0.8378 | |
Chemotherapy for rPDAC | Yes vs. No | 0.14 | 0.08 | 0.24 | <.0001 |
Margin negative resection | Yes vs. No | 0.57 | 0.35 | 0.93 | 0.0245 |
Lymphovascular invasion | Yes vs. No | 1.15 | 0.69 | 1.92 | 0.5937 |
Radiotherapy for rPDAC | Yes vs. No | 0.28 | 0.14 | 0.53 | <.0001 |
Perioperative therapy | Yes vs. No | 1.81 | 1.02 | 3.22 | 0.0417 |
Ca19–9 level at recurrence | Above 1000 U/ml | 1.012 | 1.002 | 1.023 | 0.0237 |
CA19–9 level at diagnosis | Above 1000 U/ml | 1.066 | 1.014 | 1.122 | 0.0131 |